[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 35 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. CON. RES. 35
Requiring Members of the House of Representatives and the Senate to
participate in random drug testing.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 5, 2025
Mr. Higgins of Louisiana submitted the following concurrent resolution;
which was referred to the Committee on House Administration
_______________________________________________________________________
CONCURRENT RESOLUTION
Requiring Members of the House of Representatives and the Senate to
participate in random drug testing.
Resolved by the House of Representatives (the Senate concurring),
SECTION 1. SHORT TITLE.
This concurrent resolution may be cited as the ``Exposing
Congressional Drug Abuse Act''.
SEC. 2. RANDOM DRUG TESTING OF MEMBERS OF THE HOUSE OF REPRESENTATIVES
AND THE SENATE.
(a) In General.--Each Member of the House of Representatives and
the Senate shall participate in accordance with this concurrent
resolution in a program for testing for illegal use of controlled
substances.
(b) Features.--The program under this concurrent resolution shall
include the following features:
(1) Each Member of the House of Representatives and the
Senate shall be subject to a random drug test once per term of
such Member.
(2) Each confirmed positive result under the program shall
be provided as follows:
(A) To the Member involved.
(B) In the case of a Member of the House of
Representatives, to the Committee on Ethics of the
House of Representatives for such review as may be
necessary under the Rules of the House of
Representatives.
(C) In the case of a Member of the Senate, to the
Select Committee on Ethics of the Senate for such
review as may be necessary under the Standing Rules of
the Senate.
(3) The Committee on Ethics of the House of
Representatives, with respect to a Member of the House, and the
Select Committee on Ethics of the Senate, with respect to a
Member of the Senate, shall publicly disclose the identity of
each Member who refuses to participate in the program and take
other action against each such Member as appropriate.
(4) Each Member of the House of Representatives and the
Senate shall reimburse the House of Representatives or the
Senate for the cost of the random drug test of such Member
under the program.
(c) Regulations.--The Committee on House Administration of the
House of Representatives and the Committee on Rules and Administration
of the Senate shall each issue such rules and regulations as may be
necessary to carry out this concurrent resolution.
(d) Definitions.--In this concurrent resolution:
(1) Confirmed positive result.--The term ``confirmed
positive result''--
(A) means a random drug test--
(i) which has initially tested as positive
for the presence of an illegal controlled
substance;
(ii) for which the initially positive test
has been confirmed by a second test using a
different chemical process than the process
used for the initial test; and
(iii) which has been reviewed and certified
as positive by a medical review officer with
whom the House of Representatives or the Senate
has entered into a contract to perform such
reviews; and
(B) does not include a drug test which shows only
the presence of legal, over-the-counter drugs and drugs
that have been legally prescribed for the individual
involved.
(2) Controlled substance.--The term ``controlled
substance'' has the meaning given the term in section 102 of
the Controlled Substances Act (21 U.S.C. 802).
(3) Member.--The term ``Member'', with respect to the House
of Representatives, includes a Delegate or Resident
Commissioner to the Congress.
(4) Random drug test.--The term ``random drug test'' means
a test conducted for the purpose of detecting the illegal use
of a controlled substance which is conducted--
(A) on a periodic basis;
(B) without advance notice; and
(C) without individualized suspicion.
<all>